Geneva Partners’s Axon Enterprise AXON Stock Holding History

Geneva Partners’s Portfolio AXON Stock Details AXON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-641	Closed	-$531K	–	70
2025 Q2	$531K	Buy	+641	New	+$436K	0.21%	54

Other funds holding AXON

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geneva Partners's AXON Position: Q3 2025 in Review

Geneva Partners sold out of Axon Enterprise (AXON) in Q3 2025, closing a stake of 641 shares — an estimated $531K sold.

Geneva Partners first reported a position in AXON in Q2 2025 and held it in 1 quarter. The position peaked at $531K in Q2 2025. 1,173 funds tracked by Wall St. Rank hold AXON as of Q3 2025.

Geneva Partners reported no remaining Axon Enterprise position as of Q3 2025 after selling out during the quarter.
Geneva Partners sold 641 Axon Enterprise shares in Q3 2025, an estimated $531K.
Geneva Partners first reported a position in Axon Enterprise in Q2 2025 and held it in 1 quarter.
Geneva Partners's Axon Enterprise position peaked at $531K in Q2 2025.
1,173 funds tracked by Wall St. Rank held Axon Enterprise as of Q3 2025.

Based on Geneva Partners's 13F filing for Q3 2025, filed 12 Nov 2025.